Day One Biopharmaceuticals Inc (DAWN) Directors and Executive Officers

Officers & Directors

Garry Nicholson, M.B.A.
Chair and Director

Dan Becker, M.D., Ph.D.
Director

Michael Gladstone
Director

Charles N. York II, M.B.A.
Chief Operating Officer and Chief Financial Officer (Principal Financial and Accounting Officer)

Jeremy Bender, Ph.D., M.B.A.
Chief Executive Officer and President (Principal Executive Officer)

Scott Garland
Director

John A. Josey, Ph.D., M.B.A.
Director

Habib Dable
Director

William Grossman, M.D., Ph.D.
Director

Natalie Holles
Director

Saira Ramasastry, M.S., M.Phil.
Director

Dallas, Texas,

Day One Biopharmaceuticals Inc currently has 178 employees.

News about Day One Biopharmaceuticals Inc Key Personnel

Day One Biopharmaceuticals Secures Oversubscribed $175 Million Private Placement, While Maintaining Highest ROI Ranking in Healthcare Sector

BRISBANE, Calif., July 30, 2024 - Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) has made significant strides in securing funding for its mission of developing and commercializing targeted therapies for individuals with life-threatening diseases. The commercial-stage biopharmaceutical company recently announced an oversubscribed private placement of its securities, raising approximately $175.0 million in gross proceeds. This achievement comes as a positive development for Day One, especially considering its previous net loss of $-40 million during the 12 months ending in the third quarter of 2023.
The success of Day One s private placement demonstrates the confidence investors have in the company s...